DLin-KC2-DMA, 25mg

[1-(Pentan-3-yl)piperidin-4-yl]methanamine dihydrochloride, 95.0%, 1g

2,6-Dimethoxy-3-pyridinol, 95+%, 500mg

(S)-Ethyl 2-((4-((3-chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)amino)-2-oxoacetate (Afatinib Impurity), 98%, 50mg

3-Chloro-N-(piperidin-4-yl)benzamide hydrochloride, 1g

1,4-Dioxa-8-azaspiro[4.5]decane, 97.0%, 25g

(6-Bromoimidazo[1,2-a]pyridin-2-yl)acetic acid, 97.0%, 10g

(S)-N,N-Dimethyl-1-(morpholin-2-yl)methanamine, 95+%, 1g

2-Cyclopentyl-L-glycine, 97.0%, 1g

2,5-Difluorophenylacetic acid, 96.0%, 100g

(6-(Pyridin-3-yloxy)pyridin-3-yl)boronic acid, 97%, 1g

N-[(9R)-6′-Methoxycinchonan-9-yl]-8-quinolinesulfonamide, 100mg

(S)-2-Phenyl-6-(trifluoromethyl)-2,3-dihydroimidazo[1,2-a]pyridine, 97%, 1g